Sally W Wade

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Cross Sectional

Acute Lymphoblastic Leukemia

Top Venues

Journal of medical economics

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Svenja Petersohn, Gilles Andre Salles, Michael L Wang, James J Wu, Sally W Wade, Claire L Simons, Craig Bennison, Rubina Siddiqi, Weimin Peng, Ioana Kloos, Gab Castaigne, Georg Hess
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England. Journal of medical economics 25 (1) (2022)
Claire L Simons, Daniel C Malone, Michael L Wang, Gregory A Maglinte, Timothy J Inocencio, Sally W Wade, Craig Bennison, Bijal D Shah
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States. Journal of medical economics 24 (1) (2021)
Jaime Fergie, Mitchell Goldstein, Leonard R Krilov, Sally W Wade, Amanda M Kong, Lance Brannman
Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017. Human vaccines & immunotherapeutics 17 (5) (2020)